User Tools

Site Tools


shizuoka_cancer_center

Shizuoka Cancer Center

Division of Neurosurgery, Shizuoka Cancer Center, Japan.

Mitsuya K, Nakasu Y, Hayashi N, Deguchi S, Takahashi T, Murakami H, Naito T, Kenmotsu H, Ono A, Wakuda K, Harada H. Palliative cerebrospinal fluid shunting for leptomeningeal metastasis-related hydrocephalus in patients with lung adenocarcinoma: A single-center retrospective study. PLoS One. 2019 Jan 10;14(1):e0210074. doi: 10.1371/journal.pone.0210074. eCollection 2019. PubMed PMID: 30629621.

2: Fukuoka K, Kanemura Y, Shofuda T, Fukushima S, Yamashita S, Narushima D, Kato M, Honda-Kitahara M, Ichikawa H, Kohno T, Sasaki A, Hirato J, Hirose T, Komori T, Satomi K, Yoshida A, Yamasaki K, Nakano Y, Takada A, Nakamura T, Takami H, Matsushita Y, Suzuki T, Nakamura H, Makino K, Sonoda Y, Saito R, Tominaga T, Matsusaka Y, Kobayashi K, Nagane M, Furuta T, Nakada M, Narita Y, Hirose Y, Ohba S, Wada A, Shimizu K, Kurozumi K, Date I, Fukai J, Miyairi Y, Kagawa N, Kawamura A, Yoshida M, Nishida N, Wataya T, Yamaoka M, Tsuyuguchi N, Uda T, Takahashi M, Nakano Y, Akai T, Izumoto S, Nonaka M, Yoshifuji K, Kodama Y, Mano M, Ozawa T, Ramaswamy V, Taylor MD, Ushijima T, Shibui S, Yamasaki M, Arai H, Sakamoto H, Nishikawa R, Ichimura K; Japan Pediatric Molecular Neuro-Oncology Group (JPMNG). Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors. Acta Neuropathol Commun. 2018 Dec 4;6(1):134. doi: 10.1186/s40478-018-0630-1. PubMed PMID: 30514397; PubMed Central PMCID: PMC6278135.

3: Hayashi N, Mitsuya K, Deguchi S, Nakasu Y. [Classification of Clinical Syndromes Associated with Skull-Base Metastasis in the MR Era]. No Shinkei Geka. 2018 Oct;46(10):865-873. doi: 10.11477/mf.1436203829. Japanese. PubMed PMID: 30369488.

4: Valera ET, McConechy MK, Gayden T, Rivera B, Jones DTW, Wittmann A, Han H, Bareke E, Nikbakht H, Mikael L, Queiroz RG, Suazo VK, Phi JH, Kim SK, Park SH, Fukaya R, Yum MS, Ko TS, de Oliveira RS, Machado HR, Brassesco MS, do Santos AC, Simão GN, Ramalho LNZ, Neder L, Scrideli CA, Tone LG, Majewski J, Jabado N. Methylome analysis and whole-exome sequencing reveal that brain tumors associated with encephalocraniocutaneous lipomatosis are midline pilocytic astrocytomas. Acta Neuropathol. 2018 Oct;136(4):657-660. doi: 10.1007/s00401-018-1898-8. Epub 2018 Aug 24. PubMed PMID: 30143858; PubMed Central PMCID: PMC6132939.

5: Adachi H, Hanakita J, Takahashi T, Kawaoka T, Ohtake Y, Shimizu K, Sagae Y. Precocious Solitary Cervical Metastasis from Endometrial Cancer Presenting as Cervical Radicular Pain. World Neurosurg. 2018 Oct;118:162-167. doi: 10.1016/j.wneu.2018.07.042. Epub 2018 Jul 18. PubMed PMID: 30030186.

6: Okuda T, Hayashi N, Takahashi M, Uzuka T, Okita Y, Otani R, Fujinaka T, Fujita M, Kato A, Narita Y, Nakasu Y. Clinical outcomes of brain metastases from hepatocellular carcinoma: a multicenter retrospective study and a literature review. Int J Clin Oncol. 2018 Dec;23(6):1095-1100. doi: 10.1007/s10147-018-1312-5. Epub 2018 Jul 2. Review. PubMed PMID: 29968168.

7: Nakasu Y, Mitsuya K, Deguchi S, Hayashi N, Harada H. [Surgical Resection of Metastatic Brain Tumors:Risk of Local Recurrence and Leptomeningeal Dissemination, and Implications for Individualized Treatment]. No Shinkei Geka. 2018 Mar;46(3):185-195. doi: 10.11477/mf.1436203703. Japanese. PubMed PMID: 29567868.

8: Wakabayashi T, Natsume A, Mizusawa J, Katayama H, Fukuda H, Sumi M, Nishikawa R, Narita Y, Muragaki Y, Maruyama T, Ito T, Beppu T, Nakamura H, Kayama T, Sato S, Nagane M, Mishima K, Nakasu Y, Kurisu K, Yamasaki F, Sugiyama K, Onishi T, Iwadate Y, Terasaki M, Kobayashi H, Matsumura A, Ishikawa E, Sasaki H, Mukasa A, Matsuo T, Hirano H, Kumabe T, Shinoura N, Hashimoto N, Aoki T, Asai A, Abe T, Yoshino A, Arakawa Y, Asano K, Yoshimoto K, Shibui S; Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG). JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma. J Neurooncol. 2018 Jul;138(3):627-636. doi: 10.1007/s11060-018-2831-7. Epub 2018 Mar 20. PubMed PMID: 29557060; PubMed Central PMCID: PMC5999164.

9: Nitta N, Moritani S, Fukami T, Yoshimura Y, Hirai H, Nozaki K. Intraventricular Epithelioid Glioblastoma: A Case Report. World Neurosurg. 2018 Apr;112:257-263. doi: 10.1016/j.wneu.2018.01.200. Epub 2018 Feb 6. Erratum in: World Neurosurg. 2018 Dec 11;:. PubMed PMID: 29425978.

10: Wang G, Guo S, Xiao H, Zong L, Asakawa T, Abe M, Hu W, Ji J. Remarkably different results between two studies from North America on genomic mutations and sensitivity to DNA demethylating agents for myelodysplastic syndromes. Chin J Cancer Res. 2017 Dec;29(6):587-588. doi: 10.21147/j.issn.1000-9604.2017.06.14. PubMed PMID: 29353982; PubMed Central PMCID: PMC5775012.

11: Kuwahara K, Kudo K, Yashima-Abo A, Katayama K, Kojima K, Tone K, Ito E, Nakazawa A, Iwafuchi H, Kurose A. Classic Hodgkin lymphoma with osseous involvement mimicking Langerhans cell histiocytosis in a child. Hum Pathol. 2018 Jul;77:147-151. doi: 10.1016/j.humpath.2017.12.016. Epub 2018 Jan 4. PubMed PMID: 29307624.

12: Yamamoto Y, Tomiyama A, Sasaki N, Yamaguchi H, Shirakihara T, Nakashima K, Kumagai K, Takeuchi S, Toyooka T, Otani N, Wada K, Narita Y, Ichimura K, Sakai R, Namba H, Mori K. Intracellular cholesterol level regulates sensitivity of glioblastoma cells against temozolomide-induced cell death by modulation of caspase-8 activation via death receptor 5-accumulation and activation in the plasma membrane lipid raft. Biochem Biophys Res Commun. 2018 Jan 1;495(1):1292-1299. doi: 10.1016/j.bbrc.2017.11.113. Epub 2017 Nov 21. PubMed PMID: 29162448.

13: Deguchi S, Mitsuya K, Nakasu Y, Hayashi N, Katagiri H, Murata H, Wasa J, Takahashi M, Endo M. Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature. Invest New Drugs. 2018 Apr;36(2):346-349. doi: 10.1007/s10637-017-0521-5. Epub 2017 Oct 25. PubMed PMID: 29067537; PubMed Central PMCID: PMC5869870.

14: Aoki K, Nakamura H, Suzuki H, Matsuo K, Kataoka K, Shimamura T, Motomura K, Ohka F, Shiina S, Yamamoto T, Nagata Y, Yoshizato T, Mizoguchi M, Abe T, Momii Y, Muragaki Y, Watanabe R, Ito I, Sanada M, Yajima H, Morita N, Takeuchi I, Miyano S, Wakabayashi T, Ogawa S, Natsume A. Prognostic relevance of genetic alterations in diffuse lower-grade gliomas. Neuro Oncol. 2018 Jan 10;20(1):66-77. doi: 10.1093/neuonc/nox132. PubMed PMID: 29016839; PubMed Central PMCID: PMC5761527.

15: Minami N, Maeda Y, Shibao S, Arima Y, Ohka F, Kondo Y, Maruyama K, Kusuhara M, Sasayama T, Kohmura E, Saya H, Sampetrean O. Organotypic brain explant culture as a drug evaluation system for malignant brain tumors. Cancer Med. 2017 Nov;6(11):2635-2645. doi: 10.1002/cam4.1174. Epub 2017 Oct 4. PubMed PMID: 28980419; PubMed Central PMCID: PMC5673912.

16: Hayashi N, Mitsuya K, Nakasu Y, Naito T, Ohka F, Takahashi T. Negative impact of leukoaraiosis on the incidence of brain metastases in patients with lung cancer. J Neurooncol. 2017 Nov;135(2):299-306. doi: 10.1007/s11060-017-2574-x. Epub 2017 Jul 27. PubMed PMID: 28752500; PubMed Central PMCID: PMC5663801.

17: Uzuka T, Takahashi H, Nakasu Y, Okuda T, Mitsuya K, Hayashi N, Hirose T, Kurai H. Surgical Site Infection after Malignant Brain Tumor Resection: A Multicenter Study for Induction of a Basic Care Bundle. Neurol Med Chir (Tokyo). 2017 Oct 15;57(10):542-547. doi: 10.2176/nmc.oa.2017-0034. Epub 2017 Jul 26. PubMed PMID: 28747588; PubMed Central PMCID: PMC5638781.

18: Akiyama Y, Nonomura C, Ashizawa T, Iizuka A, Kondou R, Miyata H, Sugino T, Mitsuya K, Hayashi N, Nakasu Y, Asai A, Ito M, Kiyohara Y, Yamaguchi K. The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line. Immunol Lett. 2017 Oct;190:20-25. doi: 10.1016/j.imlet.2017.07.005. Epub 2017 Jul 15. PubMed PMID: 28716484.

19: Hayashi N, Takahashi H, Hasegawa Y, Higuchi F, Takahashi M, Makino K, Takagaki M, Akimoto J, Okuda T, Okita Y, Mitsuya K, Hirashima Y, Narita Y, Nakasu Y; Committee of Brain Tumor Registry of Japan Supported by the Japan Neurosurgical Society. A nationwide multi-institutional retrospective study to identify prognostic factors and develop a graded prognostic assessment system for patients with brain metastases from uterine corpus and cervical cancer. BMC Cancer. 2017 Jun 2;17(1):397. doi: 10.1186/s12885-017-3358-6. PubMed PMID: 28577359; PubMed Central PMCID: PMC5457613.

20: Kimura T, Nagata Y, Harada H, Hayashi S, Matsuo Y, Takanaka T, Kokubo M, Takayama K, Onishi H, Hirakawa K, Shioyama Y, Ehara T. Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1). Int J Clin Oncol. 2017 Oct;22(5):849-856. doi: 10.1007/s10147-017-1125-y. Epub 2017 May 2. PubMed PMID: 28466183.

21: Yamauchi Y, Isaka M, Ando K, Mori K, Kojima H, Maniwa T, Takahashi S, Ando E, Ohde Y. Continuous paravertebral block using a thoracoscopic catheter-insertion technique for postoperative pain after thoracotomy: a retrospective case-control study. J Cardiothorac Surg. 2017 Jan 25;12(1):5. doi: 10.1186/s13019-017-0566-8. PubMed PMID: 28122571; PubMed Central PMCID: PMC5264291.

22: Mitsuya K, Nakasu Y, Ono S, Hayashi N, Watanabe R, Ito I. [Cotton-Dam Wash Cytology:A Technique for Diagnosis and Prevention of Dissemination during Resection of Metastatic Brain Tumors]. No Shinkei Geka. 2017 Jan;45(1):29-32. doi: 10.11477/mf.1436203443. Japanese. PubMed PMID: 28100859.

23: Matsuo S, Watanabe J, Mitsuya K, Hayashi N, Nakasu Y, Hayashi M. Brain metastasis in patients with metastatic breast cancer in the real world: a single-institution, retrospective review of 12-year follow-up. Breast Cancer Res Treat. 2017 Feb;162(1):169-179. doi: 10.1007/s10549-017-4107-x. Epub 2017 Jan 13. PubMed PMID: 28084583.

24: Fukushima S, Yamashita S, Kobayashi H, Takami H, Fukuoka K, Nakamura T, Yamasaki K, Matsushita Y, Nakamura H, Totoki Y, Kato M, Suzuki T, Mishima K, Yanagisawa T, Mukasa A, Saito N, Kanamori M, Kumabe T, Tominaga T, Nagane M, Iuchi T, Yoshimoto K, Mizoguchi M, Tamura K, Sakai K, Sugiyama K, Nakada M, Yokogami K, Takeshima H, Kanemura Y, Matsuda M, Matsumura A, Kurozumi K, Ueki K, Nonaka M, Asai A, Kawahara N, Hirose Y, Takayama T, Nakazato Y, Narita Y, Shibata T, Matsutani M, Ushijima T, Nishikawa R, Ichimura K; Intracranial Germ Cell Tumor Genome Analysis Consortium (The iGCTConsortium). Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas. Acta Neuropathol. 2017 Mar;133(3):445-462. doi: 10.1007/s00401-017-1673-2. Epub 2017 Jan 11. PubMed PMID: 28078450.

25: Miyata H, Ashizawa T, Iizuka A, Kondou R, Nonomura C, Sugino T, Urakami K, Asai A, Hayashi N, Mitsuya K, Nakasu Y, Yamaguchi K, Akiyama Y. Combination of a STAT3 Inhibitor and an mTOR Inhibitor Against a Temozolomide-resistant Glioblastoma Cell Line. Cancer Genomics Proteomics. 2017 Jan 2;14(1):83-91. PubMed PMID: 28031240; PubMed Central PMCID: PMC5267503.

26: Torchia J, Golbourn B, Feng S, Ho KC, Sin-Chan P, Vasiljevic A, Norman JD, Guilhamon P, Garzia L, Agamez NR, Lu M, Chan TS, Picard D, de Antonellis P, Khuong-Quang DA, Planello AC, Zeller C, Barsyte-Lovejoy D, Lafay-Cousin L, Letourneau L, Bourgey M, Yu M, Gendoo DMA, Dzamba M, Barszczyk M, Medina T, Riemenschneider AN, Morrissy AS, Ra YS, Ramaswamy V, Remke M, Dunham CP, Yip S, Ng HK, Lu JQ, Mehta V, Albrecht S, Pimentel J, Chan JA, Somers GR, Faria CC, Roque L, Fouladi M, Hoffman LM, Moore AS, Wang Y, Choi SA, Hansford JR, Catchpoole D, Birks DK, Foreman NK, Strother D, Klekner A, Bognár L, Garami M, Hauser P, Hortobágyi T, Wilson B, Hukin J, Carret AS, Van Meter TE, Hwang EI, Gajjar A, Chiou SH, Nakamura H, Toledano H, Fried I, Fults D, Wataya T, Fryer C, Eisenstat DD, Scheinemann K, Fleming AJ, Johnston DL, Michaud J, Zelcer S, Hammond R, Afzal S, Ramsay DA, Sirachainan N, Hongeng S, Larbcharoensub N, Grundy RG, Lulla RR, Fangusaro JR, Druker H, Bartels U, Grant R, Malkin D, McGlade CJ, Nicolaides T, Tihan T, Phillips J, Majewski J, Montpetit A, Bourque G, Bader GD, Reddy AT, Gillespie GY, Warmuth-Metz M, Rutkowski S, Tabori U, Lupien M, Brudno M, Schüller U, Pietsch T, Judkins AR, Hawkins CE, Bouffet E, Kim SK, Dirks PB, Taylor MD, Erdreich-Epstein A, Arrowsmith CH, De Carvalho DD, Rutka JT, Jabado N, Huang A. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors. Cancer Cell. 2016 Dec 12;30(6):891-908. doi: 10.1016/j.ccell.2016.11.003. PubMed PMID: 27960086; PubMed Central PMCID: PMC5500911.

27: Mitsuya K, Nakasu Y, Kurakane T, Hayashi N, Harada H, Nozaki K. Elevated preoperative neutrophil-to-lymphocyte ratio as a predictor of worse survival after resection in patients with brain metastasis. J Neurosurg. 2017 Aug;127(2):433-437. doi: 10.3171/2016.8.JNS16899. Epub 2016 Dec 2. PubMed PMID: 27911233.

28: Miyakawa A, Shibamoto Y, Takemoto S, Serizawa T, Otsuka S, Hirai T. Fractionated stereotactic radiotherapy for metastatic brain tumors that recurred after gamma knife radiosurgery results in acceptable toxicity and favorable local control. Int J Clin Oncol. 2017 Apr;22(2):250-256. doi: 10.1007/s10147-016-1058-x. Epub 2016 Nov 8. PubMed PMID: 27826659.

29: Nakasu Y, Mitsuya K, Hayashi N. [Update Knowledge for Brain Tumors(11)Metastatic Brain Tumors]. No Shinkei Geka. 2016 Oct;44(10):881-895. Japanese. PubMed PMID: 27729610.

30: Akiyama Y, Nonomura C, Kondou R, Miyata H, Ashizawa T, Maeda C, Mitsuya K, Hayashi N, Nakasu Y, Yamaguchi K. Immunological effects of the anti-programmed death-1 antibody on human peripheral blood mononuclear cells. Int J Oncol. 2016 Sep;49(3):1099-107. doi: 10.3892/ijo.2016.3586. Epub 2016 Jun 29. PubMed PMID: 27573705.

31: Niibe Y, Nishimura T, Inoue T, Karasawa K, Shioyama Y, Jingu K, Shirato H. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects. BMC Cancer. 2016 Aug 19;16(1):659. doi: 10.1186/s12885-016-2680-8. PubMed PMID: 27542716; PubMed Central PMCID: PMC4992231.

32: Ashizawa T, Iizuka A, Nonomura C, Kondou R, Maeda C, Miyata H, Sugino T, Mitsuya K, Hayashi N, Nakasu Y, Maruyama K, Yamaguchi K, Katano I, Ito M, Akiyama Y. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse. Clin Cancer Res. 2017 Jan 1;23(1):149-158. doi: 10.1158/1078-0432.CCR-16-0122. Epub 2016 Jul 25. PubMed PMID: 27458246.

33: Mitsuya K, Watanabe J, Nakasu Y, Hayashi N, Harada H, Ito I. Expansive hematoma in delayed cerebral radiation necrosis in patients treated with T-DM1: a report of two cases. BMC Cancer. 2016 Jul 4;16:391. doi: 10.1186/s12885-016-2464-1. PubMed PMID: 27377061; PubMed Central PMCID: PMC4932671.

34: Ishihara T, Yamada K, Harada A, Isogai K, Tonosaki Y, Demizu Y, Miyawaki D, Yoshida K, Ejima Y, Sasaki R. Hypofractionated stereotactic radiotherapy for brain metastases from lung cancer : Evaluation of indications and predictors of local control. Strahlenther Onkol. 2016 Jun;192(6):386-93. doi: 10.1007/s00066-016-0963-2. Epub 2016 May 11. PubMed PMID: 27169391.

35: Hayashi N, Mitsuya K, Harada H, Watanabe J, Nishimura T, Nakasu Y. [Leptomeningeal Dissemination in Patients with Pituitary Metastasis from Breast Cancer]. No Shinkei Geka. 2016 May;44(5):371-6. doi: 10.11477/mf.1436203293. Japanese. PubMed PMID: 27166841.

36: Nakasu Y, Mitsuya K, Hayashi N, Okamura I, Mori K, Enami T, Tatara R, Nakasu S, Ikeda T. Response-adapted treatment with upfront high-dose chemotherapy followed by autologous stem-cell transplantation rescue or consolidation phase high-dose methotrexate for primary central nervous system lymphoma: a long-term mono-center study. Springerplus. 2016 Mar 10;5:307. doi: 10.1186/s40064-016-1954-6. eCollection 2016. PubMed PMID: 27066340; PubMed Central PMCID: PMC4786507.

37: Thompson EM, Hielscher T, Bouffet E, Remke M, Luu B, Gururangan S, McLendon RE, Bigner DD, Lipp ES, Perreault S, Cho YJ, Grant G, Kim SK, Lee JY, Rao AAN, Giannini C, Li KKW, Ng HK, Yao Y, Kumabe T, Tominaga T, Grajkowska WA, Perek-Polnik M, Low DCY, Seow WT, Chang KTE, Mora J, Pollack IF, Hamilton RL, Leary S, Moore AS, Ingram WJ, Hallahan AR, Jouvet A, Fèvre-Montange M, Vasiljevic A, Faure-Conter C, Shofuda T, Kagawa N, Hashimoto N, Jabado N, Weil AG, Gayden T, Wataya T, Shalaby T, Grotzer M, Zitterbart K, Sterba J, Kren L, Hortobágyi T, Klekner A, László B, Pócza T, Hauser P, Schüller U, Jung S, Jang WY, French PJ, Kros JM, van Veelen MC, Massimi L, Leonard JR, Rubin JB, Vibhakar R, Chambless LB, Cooper MK, Thompson RC, Faria CC, Carvalho A, Nunes S, Pimentel J, Fan X, Muraszko KM, López-Aguilar E, Lyden D, Garzia L, Shih DJH, Kijima N, Schneider C, Adamski J, Northcott PA, Kool M, Jones DTW, Chan JA, Nikolic A, Garre ML, Van Meir EG, Osuka S, Olson JJ, Jahangiri A, Castro BA, Gupta N, Weiss WA, Moxon-Emre I, Mabbott DJ, Lassaletta A, Hawkins CE, Tabori U, Drake J, Kulkarni A, Dirks P, Rutka JT, Korshunov A, Pfister SM, Packer RJ, Ramaswamy V, Taylor MD. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis. Lancet Oncol. 2016 Apr;17(4):484-495. doi: 10.1016/S1470-2045(15)00581-1. Epub 2016 Mar 12. PubMed PMID: 26976201; PubMed Central PMCID: PMC4907853.

38: Nakasu Y, Mitsuya K, Hayashi N, Ito I. [Two Surgical Techniques for Metastatic Brain Tumors:Minimum Resection and Removal with Safety Margin]. No Shinkei Geka. 2016 Mar;44(3):221-6. doi: 10.11477/mf.1436203260. Japanese. PubMed PMID: 26965063.

39: Mitsuya K, Nakasu Y, Hayashi N, Yasui H, Ikeda T, Kuji S, Onozawa Y, Endo M. [Posterior Reversible Encephalopathy Syndrome Associated with Cancer Therapy]. No Shinkei Geka. 2016 Mar;44(3):211-9. doi: 10.11477/mf.1436203259. Japanese. PubMed PMID: 26965062.

40: Cui R, Guan Y, Sun C, Chen L, Bao Y, Li G, Qiu B, Meng X, Pang C, Wang Y. A tumor-suppressive microRNA, miR-504, inhibits cell proliferation and promotes apoptosis by targeting FOXP1 in human glioma. Cancer Lett. 2016 Apr 28;374(1):1-11. doi: 10.1016/j.canlet.2016.01.051. Epub 2016 Feb 10. PubMed PMID: 26854715.

41: Mitsuya K, Nakasu Y, Narita Y, Nakasu S, Ohno M, Miyakita Y, Abe M, Ito I, Hayashi N, Endo M. “Comet tail sign”: A pitfall of post-gadolinium magnetic resonance imaging findings for metastatic brain tumors. J Neurooncol. 2016 May;127(3):589-95. doi: 10.1007/s11060-016-2069-1. Epub 2016 Feb 2. PubMed PMID: 26839020; PubMed Central PMCID: PMC4835516.

42: Shiina S, Ohno M, Ohka F, Kuramitsu S, Yamamichi A, Kato A, Motomura K, Tanahashi K, Yamamoto T, Watanabe R, Ito I, Senga T, Hamaguchi M, Wakabayashi T, Kaneko MK, Kato Y, Chandramohan V, Bigner DD, Natsume A. CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains. Cancer Immunol Res. 2016 Mar;4(3):259-68. doi: 10.1158/2326-6066.CIR-15-0060. Epub 2016 Jan 28. PubMed PMID: 26822025.

43: Murai T, Sato K, Iwabuchi M, Manabe Y, Ogino H, Iwata H, Tatewaki K, Yokota N, Ohta S, Shibamoto Y. Re-irradiation of recurrent anaplastic ependymoma using radiosurgery or fractionated stereotactic radiotherapy. Jpn J Radiol. 2016 Mar;34(3):211-8. doi: 10.1007/s11604-015-0511-5. Epub 2015 Dec 18. Erratum in: Jpn J Radiol. 2016 Mar;34(3):219. PubMed PMID: 26682738.

44: Sitthinamsuwan B, Usui N, Tottori T, Terada K, Kondo A, Matsuda K, Baba K, Inoue Y. Seizures with tonic posturing: Semiologic difference between supplementary sensorimotor area (SSMA) origin and extra-SSMA origin. Epilepsia. 2016 Feb;57(2):e39-44. doi: 10.1111/epi.13283. Epub 2015 Dec 13. PubMed PMID: 26660199.

45: Ozawa Y, Omae M, Fujii M, Matsui T, Kato M, Sagisaka S, Asada K, Karayama M, Shirai T, Yasuda K, Nakamura Y, Inui N, Yamada K, Yokomura K, Suda T. Management of brain metastasis with magnetic resonance imaging and stereotactic irradiation attenuated benefits of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer. BMC Cancer. 2015 Aug 15;15:589. doi: 10.1186/s12885-015-1593-2. PubMed PMID: 26275617; PubMed Central PMCID: PMC4537586.

46: Bell D, Hanna EY, Weber RS, DeMonte F, Triantafyllou A, Lewis JS Jr, Cardesa A, Slootweg PJ, Stenman G, Gnepp DR, Devaney KO, Rodrigo JP, Rinaldo A, Wenig BM, Westra WH, Bishop JA, Hellquist H, Hunt JL, Kusafuka K, Perez-Ordoñez B, Williams MD, Takes RP, Ferlito A. Neuroendocrine neoplasms of the sinonasal region. Head Neck. 2016 Apr;38 Suppl 1:E2259-66. doi: 10.1002/hed.24152. Epub 2015 Jul 18. Review. PubMed PMID: 26041714.

47: Torchia J, Picard D, Lafay-Cousin L, Hawkins CE, Kim SK, Letourneau L, Ra YS, Ho KC, Chan TS, Sin-Chan P, Dunham CP, Yip S, Ng HK, Lu JQ, Albrecht S, Pimentel J, Chan JA, Somers GR, Zielenska M, Faria CC, Roque L, Baskin B, Birks D, Foreman N, Strother D, Klekner A, Garami M, Hauser P, Hortobágyi T, Bognár L, Wilson B, Hukin J, Carret AS, Van Meter TE, Nakamura H, Toledano H, Fried I, Fults D, Wataya T, Fryer C, Eisenstat DD, Scheineman K, Johnston D, Michaud J, Zelcer S, Hammond R, Ramsay DA, Fleming AJ, Lulla RR, Fangusaro JR, Sirachainan N, Larbcharoensub N, Hongeng S, Barakzai MA, Montpetit A, Stephens D, Grundy RG, Schüller U, Nicolaides T, Tihan T, Phillips J, Taylor MD, Rutka JT, Dirks P, Bader GD, Warmuth-Metz M, Rutkowski S, Pietsch T, Judkins AR, Jabado N, Bouffet E, Huang A. Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis. Lancet Oncol. 2015 May;16(5):569-82. doi: 10.1016/S1470-2045(15)70114-2. Epub 2015 Apr 14. PubMed PMID: 25882982.

48: Suzuki H, Aoki K, Chiba K, Sato Y, Shiozawa Y, Shiraishi Y, Shimamura T, Niida A, Motomura K, Ohka F, Yamamoto T, Tanahashi K, Ranjit M, Wakabayashi T, Yoshizato T, Kataoka K, Yoshida K, Nagata Y, Sato-Otsubo A, Tanaka H, Sanada M, Kondo Y, Nakamura H, Mizoguchi M, Abe T, Muragaki Y, Watanabe R, Ito I, Miyano S, Natsume A, Ogawa S. Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet. 2015 May;47(5):458-68. doi: 10.1038/ng.3273. Epub 2015 Apr 13. PubMed PMID: 25848751.

49: Hayashi N, Mitsuya K, Gorai K, Inoue K, Ito I, Nakagawa M, Nakasu Y. A novel graft material for preventing cerebrospinal fluid leakage in skull base reconstruction: technical note of perifascial areolar tissue. J Neurol Surg B Skull Base. 2015 Feb;76(1):7-11. doi: 10.1055/s-0034-1386655. Epub 2014 Aug 11. PubMed PMID: 25685643; PubMed Central PMCID: PMC4318742.

50: Matsumoto R, Mikuni N, Tanaka K, Usami K, Fukao K, Kunieda T, Takahashi Y, Miyamoto S, Fukuyama H, Takahashi R, Ikeda A. Possible induction of multiple seizure foci due to parietal tumour and anti-NMDAR antibody. Epileptic Disord. 2015 Mar;17(1):89-94; quiz 94. doi: 10.1684/epd.2015.0725. PubMed PMID: 25644722.

51: Iwata H, Inoue M, Shiomi H, Murai T, Tatewaki K, Ohta S, Okawa K, Yokota N, Shibamoto Y. Evaluation of Dose Uncertainty to the Target Associated With Real-Time Tracking Intensity-Modulated Radiation Therapy Using the CyberKnife Synchrony System. Technol Cancer Res Treat. 2016 Feb;15(1):101-6. doi: 10.1177/1533034614563443. Epub 2014 Dec 16. PubMed PMID: 25520272.

52: Yamakawa Y, Moriguchi M, Aramaki T, Mitsuya K, Asakura K, Sawada A, Endo M, Nakasu Y. Brain metastasis from hepatocellular carcinoma: The impact of radiotherapy on control of intracranial hemorrhage. Hepatol Res. 2015 Nov;45(11):1071-5. doi: 10.1111/hepr.12457. Epub 2015 Jan 8. PubMed PMID: 25470452.

53: Saga I, Shibao S, Okubo J, Osuka S, Kobayashi Y, Yamada S, Fujita S, Urakami K, Kusuhara M, Yoshida K, Saya H, Sampetrean O. Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model. Neuro Oncol. 2014 Aug;16(8):1048-56. doi: 10.1093/neuonc/nou096. Epub 2014 May 23. PubMed PMID: 24860177; PubMed Central PMCID: PMC4096179.

54: Akiyama Y, Ashizawa T, Komiyama M, Miyata H, Oshita C, Omiya M, Iizuka A, Kume A, Sugino T, Hayashi N, Mitsuya K, Nakasu Y, Yamaguchi K. YKL-40 downregulation is a key factor to overcome temozolomide resistance in a glioblastoma cell line. Oncol Rep. 2014 Jul;32(1):159-66. doi: 10.3892/or.2014.3195. Epub 2014 May 16. PubMed PMID: 24842123.

55: Ashizawa T, Akiyama Y, Miyata H, Iizuka A, Komiyama M, Kume A, Omiya M, Sugino T, Asai A, Hayashi N, Mitsuya K, Nakasu Y, Yamaguchi K. Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line. Int J Oncol. 2014 Jul;45(1):411-8. doi: 10.3892/ijo.2014.2439. Epub 2014 May 12. PubMed PMID: 24820265.

56: Akiyama Y, Komiyama M, Miyata H, Yagoto M, Ashizawa T, Iizuka A, Oshita C, Kume A, Nogami M, Ito I, Watanabe R, Sugino T, Mitsuya K, Hayashi N, Nakasu Y, Yamaguchi K. Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients. Oncol Rep. 2014 Apr;31(4):1683-90. doi: 10.3892/or.2014.3049. Epub 2014 Feb 24. PubMed PMID: 24573400.

57: Iizuka A, Komiyama M, Oshita C, Kume A, Ashizawa T, Mitsuya K, Hayashi N, Nakasu Y, Yamaguchi K, Akiyama Y. Anti-vascular endothelial growth factor receptor (VEGFR) 2 autoantibody identification in glioblastoma patient using single B cell-based antibody gene cloning. Immunol Lett. 2014 May-Jun;159(1-2):15-22. doi: 10.1016/j.imlet.2014.02.004. Epub 2014 Feb 15. PubMed PMID: 24534640.

58: Mizokami Y, Mitsuya K, Hayashi N, Yasui H, Harada H, Nishimura T, Nakasu Y. [Metastatic brain tumors from gastrointestinal cancer: an analysis of patient background and treatment results]. No Shinkei Geka. 2013 Aug;41(8):669-77. Review. Japanese. PubMed PMID: 23907473.

59: Ito-Yamashita T, Nakasu Y, Mitsuya K, Mizokami Y, Namba H. Detection of tumor progression by signal intensity increase on fluid-attenuated inversion recovery magnetic resonance images in the resection cavity of high-grade gliomas. Neurol Med Chir (Tokyo). 2013;53(7):496-500. PubMed PMID: 23883561.

60: Mitsuya K, Nakasu Y, Mizokami Y, Takahashi T, Nakamura Y, Ono A, Toda Y, Yamamoto N, Harada H, Nishimura T. [Multidisciplinary treatment of leptomeningeal metastasis in patients with lung adenocarcinoma: the triple modality combination of EGFR-TKI, VP shunt and irradiation]. No Shinkei Geka. 2012 Jun;40(6):503-9. Japanese. PubMed PMID: 22647509.

61: Tomita H, Yasui H, Boku N, Nakasu Y, Mitsuya K, Onozawa Y, Fukutomi A, Yamazaki K, Machida N, Taku K, Todaka A, Taniguchi H, Tsushima T. Leptomeningeal carcinomatosis associated with gastric cancer. Int J Clin Oncol. 2012 Aug;17(4):361-6. doi: 10.1007/s10147-011-0301-8. Epub 2011 Aug 17. PubMed PMID: 21847535.

62: Horiguchi S, Mitsuya K, Watanabe R, Yagishita S, Nakasu Y. Pleomorphic xanthoastrocytoma and moyamoya disease in a patient with neurofibromatosis type 1 - case report - . Neurol Med Chir (Tokyo). 2011;51(4):310-4. PubMed PMID: 21515957.

63: Shibata S, Hanakita J, Takahashi T, Minami M, Kuraishi K, Watanabe M. Bilateral discal cysts managed by partial hemilaminectomy and microscopic resection of hemilateral cyst. Spine (Phila Pa 1976). 2011 Dec 1;36(25):E1655-8. doi: 10.1097/BRS.0b013e3182134b77. PubMed PMID: 21301393.

64: Uematsu T, Kasami M, Takahashi K, Watanabe J, Yamasaki S, Tanaka K, Tadokoro Y, Ogiya A. Clip placement after an 11-gauge vacuum-assisted stereotactic breast biopsy: correlation between breast thickness and clip movement. Breast Cancer. 2012 Jan;19(1):30-6. doi: 10.1007/s12282-011-0252-y. Epub 2011 Jan 29. PubMed PMID: 21274668.

65: Mitsuya K, Nakasu Y, Horiguchi S, Harada H, Nishimura T, Yuen S, Asakura K, Endo M. Metastatic skull tumors: MRI features and a new conventional classification. J Neurooncol. 2011 Aug;104(1):239-45. doi: 10.1007/s11060-010-0465-5. Epub 2010 Nov 26. PubMed PMID: 21110218; PubMed Central PMCID: PMC3151370.

66: Nakasu Y, Mitsuya K. [Multidisciplinary management of brain metastases]. Gan To Kagaku Ryoho. 2010 Feb;37(2):204-10. Japanese. PubMed PMID: 20154474.

67: Mitsuya K, Nakasu Y, Horiguchi S, Harada H, Nishimura T, Bando E, Okawa H, Furukawa Y, Hirai T, Endo M. Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. J Neurooncol. 2010 Aug;99(1):81-8. doi: 10.1007/s11060-009-0106-z. Epub 2010 Jan 8. PubMed PMID: 20058049.

68: Mitsuya K, Nitta N, Suzuki F. Persistent zinc depletion in the mossy fiber terminals in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy. Epilepsia. 2009 Aug;50(8):1979-90. doi: 10.1111/j.1528-1167.2009.02055.x. Epub 2009 Apr 6. PubMed PMID: 19389150.

69: Uematsu T, Kasami M, Yuen S. A cluster of microcalcifications: women with high risk for breast cancer versus other women. Breast Cancer. 2009;16(4):307-14. doi: 10.1007/s12282-009-0100-5. Epub 2009 Apr 7. PubMed PMID: 19350360.

70: Nakasu Y. [Current strategies in radiation therapy for brain metastases]. No Shinkei Geka. 2007 Jan;35(1):7-16. Review. Japanese. PubMed PMID: 17228763.

71: Nakasu Y, Nakasu S, Saito A, Horiguchi S, Kameya T. Pituicytoma. Two case reports. Neurol Med Chir (Tokyo). 2006 Mar;46(3):152-6. PubMed PMID: 16565586.

72: Fukuda H. Bilateral peroneal nerve palsy caused by intermittent pneumatic compression. Intern Med. 2006;45(2):93-4. Epub 2006 Feb 15. PubMed PMID: 16484746.

73: Watanabe T, Fuse T, Umezu M, Yamamoto M, Demura K, Niwa Y. Radiation-induced osteosarcoma 16 years after surgery and radiation for glioma–case report. Neurol Med Chir (Tokyo). 2006 Jan;46(1):51-4. PubMed PMID: 16434828.

74: Mitsuya K, Nakasu Y, Nioka H, Nakasu S. Ectopic growth hormone-releasing adenoma in the cavernous sinus–case report. Neurol Med Chir (Tokyo). 2004 Jul;44(7):380-5. Review. PubMed PMID: 15347217.

75: Tottori T, Yagi K, Mihara T, Matsuda K, Baba K, Hiyoshi T, Watanabe Y, Inoue Y, Kubota Y, Seino M. Frontal lobe epilepsy with supplementary motor seizures successfully treated with cortical resection following intracranial EEG/CCTV monitoring and functional mapping. Jpn J Psychiatry Neurol. 1993 Jun;47(2):267-70. PubMed PMID: 8271559.

76: Takami T, Sakaguchi M, Murata K, Nakabayashi H, Nakagawa O, Kawasaki H. [A case report of Weber's syndrome associated with supranuclear vertical gaze palsy caused by the ipsilateral thalamomesencephalic lesion]. No To Shinkei. 1993 May;45(5):461-4. Japanese. PubMed PMID: 8343298.

77: Mihara T, Matsuda K, Tottori T, Watanabe Y, Hiyoshi T, Yagi K, Seino M. Surgical treatment of epilepsy in the comprehensive care program: advantages and considerations. Jpn J Psychiatry Neurol. 1990 Jun;44(2):275-81. PubMed PMID: 2259011.

shizuoka_cancer_center.txt · Last modified: 2019/01/12 10:44 by administrador